Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Guth, Sabine
Tange, Thomas ∅.
Kellenberger, Esther
and
Valcárcel, Juan
2001.
Dual Function for U2AF35 in AG-Dependent Pre-mRNA Splicing.
Molecular and Cellular Biology,
Vol. 21,
Issue. 22,
p.
7673.
Zhu, Jun
Mayeda, Akila
and
Krainer, Adrian R.
2001.
Exon Identity Established through Differential Antagonism between Exonic Splicing Silencer-Bound hnRNP A1 and Enhancer-Bound SR Proteins.
Molecular Cell,
Vol. 8,
Issue. 6,
p.
1351.
Lim, Sharlene R.
and
Hertel, Klemens J.
2001.
Modulation of Survival Motor Neuron Pre-mRNA Splicing by Inhibition of Alternative 3′ Splice Site Pairing.
Journal of Biological Chemistry,
Vol. 276,
Issue. 48,
p.
45476.
Shepard, Jeremiah
Reick, Martin
Olson, Sara
and
Graveley, Brenton R.
2002.
Characterization of U2AF26, a Splicing Factor Related to U2AF35.
Molecular and Cellular Biology,
Vol. 22,
Issue. 1,
p.
221.
Furuyama, Suzanne
and
Bruzik, James P.
2002.
Multiple Roles for SR Proteins intransSplicing.
Molecular and Cellular Biology,
Vol. 22,
Issue. 15,
p.
5337.
Cartegni, Luca
Chew, Shern L.
and
Krainer, Adrian R.
2002.
Listening to silence and understanding nonsense: exonic mutations that affect splicing.
Nature Reviews Genetics,
Vol. 3,
Issue. 4,
p.
285.
Soret, J.
and
Tazi, J.
2003.
Regulation of Alternative Splicing.
Vol. 31,
Issue. ,
p.
89.
Rauch, T.
and
Kiss, Ibolya
2003.
How to find the real one.
Acta Biologica Hungarica,
Vol. 54,
Issue. 3-4,
p.
219.
Skordis, Leigh A.
Dunckley, Matthew G.
Yue, Baigong
Eperon, Ian C.
and
Muntoni, Francesco
2003.
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulatesSMN2gene expression in patient fibroblasts.
Proceedings of the National Academy of Sciences,
Vol. 100,
Issue. 7,
p.
4114.
Sanford, J. R.
Longman, D.
and
Cáceres, J. F.
2003.
Regulation of Alternative Splicing.
Vol. 31,
Issue. ,
p.
33.
Domsic, Jeffrey K.
Wang, Yibin
Mayeda, Akila
Krainer, Adrian R.
and
Stoltzfus, C. Martin
2003.
Human Immunodeficiency Virus Type 1 hnRNP A/B-Dependent Exonic Splicing Silencer ESSV Antagonizes Binding of U2AF65 to Viral Polypyrimidine Tracts.
Molecular and Cellular Biology,
Vol. 23,
Issue. 23,
p.
8762.
Lam, Bianca J.
Bakshi, Arati
Ekinci, Fatma Y.
Webb, Jenny
Graveley, Brenton R.
and
Hertel, Klemens J.
2003.
Enhancer-dependent 5′-Splice Site Control of fruitless Pre-mRNA Splicing.
Journal of Biological Chemistry,
Vol. 278,
Issue. 25,
p.
22740.
Black, Douglas L.
2003.
Mechanisms of Alternative Pre-Messenger RNA Splicing.
Annual Review of Biochemistry,
Vol. 72,
Issue. 1,
p.
291.
Boukis, Lisa A.
Liu, Nan
Furuyama, Suzanne
and
Bruzik, James P.
2004.
Ser/Arg-rich Protein-mediated Communication between U1 and U2 Small Nuclear Ribonucleoprotein Particles.
Journal of Biological Chemistry,
Vol. 279,
Issue. 28,
p.
29647.
Újvári, Andrea
and
Luse, Donal S.
2004.
Newly Initiated RNA Encounters a Factor Involved in Splicing Immediately upon Emerging from within RNA Polymerase II.
Journal of Biological Chemistry,
Vol. 279,
Issue. 48,
p.
49773.
Schnell, Stephen A.
and
Wessendorf, Martin W.
2004.
Expression of MOR1C‐like μ‐opioid receptor mRNA in rats.
Journal of Comparative Neurology,
Vol. 473,
Issue. 2,
p.
213.
Bourgeois, Cyril F
Lejeune, Fabrice
and
Stévenin, James
2004.
Vol. 78,
Issue. ,
p.
37.
Arrisi-Mercado, Pablo
Romano, Maurizio
Muro, Andres F.
and
Baralle, Francisco E.
2004.
An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3′ Splice Site of Human Apolipoprotein A-II Exon 3.
Journal of Biological Chemistry,
Vol. 279,
Issue. 38,
p.
39331.
Pacheco, Teresa R.
Gomes, Anita Q.
Barbosa-Morais, Nuno L.
Benes, Vladimir
Ansorge, Wilhelm
Wollerton, Matthew
Smith, Christopher W.
Valcárcel, Juan
and
Carmo-Fonseca, Maria
2004.
Diversity of Vertebrate Splicing Factor U2AF35.
Journal of Biological Chemistry,
Vol. 279,
Issue. 26,
p.
27039.
James, Paula D.
O'Brien, Lee A.
Hegadorn, Carol A.
Notley, Colleen R. P.
Sinclair, Gary D.
Hough, Christine
Poon, Man-Chiu
and
Lillicrap, David
2004.
A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons.
Blood,
Vol. 104,
Issue. 9,
p.
2739.